MedTrace Logo

Biomarkers and Choroidal Neovascularization

NCT04439708 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-04-25

No results posted yet for this study

Summary

The aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.

Conditions

  • Choroidal Neovascularization
  • Mineralocorticoid Excess

Interventions

OTHER

Blood and aqueous humor biomarker of treatment response

Blood analyses and aqueous humor analysis

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2027-01-06
Completion
2027-07-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439708 on ClinicalTrials.gov